openPR Logo
Press release

Treatment for Syndromes of Dementia and Movement Disorders Market is Anticipated to be Valued at US$ 21,154.8 Mn by 2020

12-01-2017 12:17 PM CET | Health & Medicine

Press release from: Persistence Market Research

Treatment for Syndromes of Dementia and Movement Disorders

According to a new market report published by Persistence Market Research “Global Market Study on Treatment for Syndromes of Dementia and Movement Disorders: Asia to Witness Highest Growth by 2020,” the global treatment for syndromes of dementia and movement disorders market was valued at USD 12,859.8 million in 2014 and is expected to grow at a CAGR of 8.6% from 2014 to 2020, to reach an estimated value of USD 21,154.8 million in 2020.
 
View Report Preview @  https://www.persistencemarketresearch.com/market-research/treatment-syndromes-dementia-movement-disorders-market.asp
 
The treatment for syndromes of dementia and movement disorders market is witnessing significant growth due to increasing R&D investments in drug discovery and developments. In addition, increasing prevalence of neurodegenerative disorders and rising awareness about mental disorders are also driving the growth of the market. However, most of the drugs fail in Phase III due to lack of sufficient knowledge about the mechanisms of the brain and the unknown causes of the disease. In addition, lack of comprehensive therapeutic management, strict regulations, and time-consuming drug approval process inhibit the growth of the market. The global treatment for syndromes of dementia and movement disorders market is anticipated to grow from an estimated USD 12,859.8 million in 2014 to USD 21,154.8 million in 2020 at a CAGR of 8.6% during the forecast period.
 
In North America, growing aging population and rising incidence of neurodegenerative disease are driving the use of treatment for syndromes of dementia and movement disorders in the market. In addition, lack of proper medication is also fuelling the growth of treatments for syndromes of dementia and movement disorders market.
 
In Europe, the treatment for syndromes of dementia and movement disorders market is driven by rising incidence of mental disorder related disease and growing aging population. On the other hand, various awareness programs were launched by public and private health institutions to control dementia and movement disorders, which would increase the use of dementia and movement disorder drugs in the region.
 
However, in Asia the growth for treatment for syndromes of dementia and movement disorders is much higher than developed countries due to widening health insurance penetration, and large population base.
 
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/2833
 
F. Hoffmann-La Roche, Ltd., Novartis AG, Merck & Co., Inc., Sanofi S.A., Valeant Pharmaceutical International, Inc., AstraZeneca GmbH and Pfizer, Inc. are some of the major players of treatment for syndromes of dementia and movement disorders market.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Treatment for Syndromes of Dementia and Movement Disorders Market is Anticipated to be Valued at US$ 21,154.8 Mn by 2020 here

News-ID: 841464 • Views:

More Releases from Persistence Market Research

Hydrolyzed Vegetable Protein Market Boom Rising from $3.3 Bn in 2025 to $5.3 Bn - Persistence Market Research
Hydrolyzed Vegetable Protein Market Boom Rising from $3.3 Bn in 2025 to $5.3 Bn …
The hydrolyzed vegetable protein (HVP) market is a key contributor to the food and beverage industry, enhancing flavor profiles and nutritional value in processed foods, nutraceuticals, personal care products, and animal feed. HVP, derived from plant-based sources such as soy, corn, and peas, is widely used as a natural flavor enhancer and protein fortification agent. Request a Sample: https://www.persistencemarketresearch.com/samples/10975 According to the latest study by Persistence Market Research, the global market
High Purity Alumina Market to Reach US$ 18.2 Bn by 2032, Driven by Rising Demand for Energy-Efficient Lighting
High Purity Alumina Market to Reach US$ 18.2 Bn by 2032, Driven by Rising Demand …
The global High Purity Alumina (HPA) market is entering a phase of rapid expansion as industries increasingly adopt advanced materials to meet the needs of modern technology. Known for its exceptional properties such as high melting point, superior hardness, chemical stability, and excellent electrical insulation, HPA has become an indispensable material across multiple high-tech industries. According to the latest study by Persistence Market Research, the global HPA market size is estimated
Conductive Carbon Black Market to Reach US$ 541.1 Million by 2025, Driven by Rising Demand from Application Industries
Conductive Carbon Black Market to Reach US$ 541.1 Million by 2025, Driven by Ris …
The global conductive carbon black market is witnessing a significant transformation as industries increasingly focus on materials that enhance conductivity, durability, and performance across a wide range of applications. According to the latest study by Persistence Market Research, the market is expected to achieve a valuation of US$ 541.1 million by 2025, expanding at a robust compound annual growth rate (CAGR) of 7.7% throughout the forecast period from 2025 to
Transparent Barrier Packaging Films Market to Reach US$34.8 Bn by 2031, Driven by Rising Demand for Sustainable Food Packaging
Transparent Barrier Packaging Films Market to Reach US$34.8 Bn by 2031, Driven b …
The global transparent barrier packaging films market is witnessing robust growth, fueled by evolving consumer preferences, the rising importance of product shelf life, and the growing push toward sustainable packaging solutions. According to the latest study by Persistence Market Research, the market is estimated to increase from US$21.9 billion in 2024 to US$34.8 billion by 2031, securing a healthy CAGR of 6.9% during the forecast period. This growth underscores the

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any